Log In
BCIQ
Print this Print this
 

Vonvendi (BAX 111, BAX111)

Also known as: rVWF

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant human von Willebrand factor (vWF)
Molecular Target von Willebrand factor (vWF)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationBleeding
Indication DetailsTreat and prevent bleeding episodes in von Willebrand disease (vWD) patients; Treat von Willebrand disease (vWD)
Regulatory Designation U.S. - Orphan Drug (Treat and prevent bleeding episodes in von Willebrand disease (vWD) patients);
EU - Orphan Drug (Treat and prevent bleeding episodes in von Willebrand disease (vWD) patients);
Japan - Orphan Drug (Treat and prevent bleeding episodes in von Willebrand disease (vWD) patients)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today